Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $27,293 | 1,176 | 96.3% |
| Consulting Fee | $924.00 | 1 | 3.3% |
| Education | $132.30 | 11 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,099 | 122 | $0 (2023) |
| ABBVIE INC. | $2,570 | 127 | $0 (2023) |
| Novo Nordisk Inc | $2,238 | 100 | $0 (2023) |
| Amgen Inc. | $1,972 | 72 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,799 | 72 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,420 | 26 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,419 | 34 | $0 (2023) |
| Allergan, Inc. | $1,377 | 74 | $0 (2020) |
| Lilly USA, LLC | $1,097 | 66 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $930.59 | 23 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,219 | 30 | GlaxoSmithKline, LLC. ($365.47) |
| 2022 | $5,255 | 173 | ABBVIE INC. ($921.71) |
| 2021 | $4,889 | 268 | AbbVie Inc. ($874.99) |
| 2020 | $4,512 | 204 | Novartis Pharmaceuticals Corporation ($937.87) |
| 2019 | $3,793 | 160 | Allergan Inc. ($517.61) |
| 2018 | $4,397 | 189 | AstraZeneca Pharmaceuticals LP ($755.00) |
| 2017 | $4,284 | 164 | Boehringer Ingelheim Pharmaceuticals, Inc. ($554.78) |
All Payment Transactions
1,188 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/11/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.63 | General |
| Category: Cardiovascular | ||||||
| 03/30/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $145.00 | General |
| 03/30/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $104.55 | General |
| 03/29/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $115.92 | General |
| Category: VACCINES | ||||||
| 03/27/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.02 | General |
| Category: Cardiovascular | ||||||
| 03/23/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $103.43 | General |
| 03/15/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Gastroenterology | ||||||
| 03/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: DIABETES | ||||||
| 03/07/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Diabetes | ||||||
| 02/28/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $101.87 | General |
| Category: Insulin Pump | ||||||
| 02/28/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: NEUROSCIENCE | ||||||
| 02/26/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $32.05 | General |
| Category: Diabetes Care | ||||||
| 02/23/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $105.67 | General |
| Category: PSYCHIATRY | ||||||
| 02/22/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Diabetes | ||||||
| 02/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Bone Health | ||||||
| 02/14/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes | ||||||
| 02/08/2023 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/06/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.66 | General |
| Category: Cardiovascular | ||||||
| 01/31/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.96 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $101.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/25/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Inflammation | ||||||
| 01/24/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 156 | 212 | $42,120 | $12,992 |
| 2022 | 10 | 541 | 1,027 | $202,440 | $82,173 |
| 2021 | 15 | 715 | 1,461 | $240,470 | $107,460 |
| 2020 | 16 | 734 | 1,543 | $238,920 | $88,539 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 58 | 69 | $16,560 | $4,944 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 71 | $13,135 | $3,282 | 25.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 25 | $5,000 | $2,283 | 45.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 31 | $5,425 | $1,881 | 34.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 15 | 16 | $2,000 | $602.50 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 361 | $66,785 | $25,743 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 127 | 179 | $42,960 | $20,705 | 48.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 61 | 149 | $29,800 | $11,327 | 38.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 43 | $12,900 | $6,433 | 49.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 50 | 116 | $20,300 | $6,206 | 30.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 19 | 22 | $7,700 | $4,562 | 59.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 39 | 54 | $13,500 | $4,151 | 30.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 29 | 35 | $4,375 | $2,170 | 49.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 21 | 36 | $2,520 | $847.78 | 33.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 25 | 32 | $1,600 | $29.28 | 1.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 166 | 468 | $80,400 | $38,604 | 48.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 140 | 155 | $35,115 | $16,370 | 46.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 57 | 165 | $28,875 | $8,984 | 31.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 45 | 58 | $17,400 | $8,732 | 50.2% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 23 | 34 | $11,900 | $7,157 | 60.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 42 | 80 | $16,000 | $6,349 | 39.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 37 | 54 | $13,500 | $4,418 | 32.7% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 13 | 51 | $6,375 | $3,265 | 51.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 53 | $6,625 | $3,104 | 46.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 16 | 23 | $5,060 | $3,051 | 60.3% |
About Dr. David Hess, M.D
Dr. David Hess, M.D is a Family Medicine healthcare provider based in Bridgeport, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1740275676.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hess, M.D has received a total of $28,349 in payments from pharmaceutical and medical device companies, with $1,219 received in 2023. These payments were reported across 1,188 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($27,293).
As a Medicare-enrolled provider, Hess has provided services to 2,146 Medicare beneficiaries, totaling 4,243 services with total Medicare billing of $291,164. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bridgeport, WV
- Active Since 09/16/2005
- Last Updated 04/04/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740275676
Products in Payments
- FARXIGA (Drug) $1,753
- XARELTO (Drug) $1,375
- ENTRESTO (Drug) $1,313
- Ozempic (Drug) $1,135
- UBRELVY (Drug) $1,121
- TRADJENTA (Drug) $846.19
- LINZESS (Drug) $783.13
- Vascepa (Drug) $737.41
- EVENITY (Biological) $689.12
- ELIQUIS (Drug) $638.67
- NUZYRA (Drug) $622.70
- VRAYLAR (Drug) $618.85
- Aimovig (Biological) $592.88
- NURTEC ODT (Drug) $589.78
- JARDIANCE (Drug) $520.87
- Trulance (Drug) $490.40
- Omnipod (Device) $413.02
- SOLIQUA 100/33 (Biological) $410.97
- FASENRA (Drug) $405.58
- FREESTYLE LIBRE 2 (Device) $383.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bridgeport
George Homa, Do, DO
Family Medicine — Payments: $13,283
Frances Murray, Md, MD
Family Medicine — Payments: $12,525
Dr. Stephen Fryer, D.o, D.O
Family Medicine — Payments: $10,194
Dr. Jackson Maille, Md, MD
Family Medicine — Payments: $9,794
Kelly Nelson, Md, MD
Family Medicine — Payments: $8,656
Brittanie West, Do, DO
Family Medicine — Payments: $7,927